PRISM BioLab Co.,LTD

206A TSE Pharmaceuticals Pharmaceutical
TSE Growth
¥162.00
-3.57%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does PRISM BioLab Co.,LTD belong to?
PRISM BioLab Co.,LTD operates in the Pharmaceuticals sector, specifically the Pharmaceutical industry, and is listed on the US markets.
What is the current share price of 206A?
As of the latest available quote, 206A traded at ¥162.00. This price is delayed and cached for about 15 minutes.
What is the market capitalisation of 206A?
The market capitalisation of PRISM BioLab Co.,LTD is approximately ¥5.92B.
Is PRISM BioLab Co.,LTD profitable?
For its latest reported financial year, PRISM BioLab Co.,LTD recorded a negative net profit margin of about -123.09% (a net loss for the latest period).
Does 206A pay a dividend?
PRISM BioLab Co.,LTD does not currently show a dividend yield in our data.
What is the return on equity (ROE) of 206A?
PRISM BioLab Co.,LTD has a return on equity (ROE) of about -30.86%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of 206A?
Over the past 52 weeks, 206A has traded between a low of ¥125.00 and a high of ¥279.00.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.